发明名称 COMBINATIONS OF 5-HT2A INVERSE AGONISTS AND ANTAGONISTS WITH ANTIPSYCHOTICS
摘要 Combinations of 5-HT2A inverse agonists or antagonists such as pimavanserin with antipsychotics such as risperidone are shown induce a rapid onset of antipsychotic action and increase the responders when compared to therapy with the antipsychotic alone. These effects can be achieved at a low dose of the antipsychotic, thereby reducing the incidence of side effects. The combinations are also effective at decreases the incidence of weight gain and increased glucose or prolactin levels caused by the antipsychotic.
申请公布号 US2015231126(A1) 申请公布日期 2015.08.20
申请号 US201514702313 申请日期 2015.05.01
申请人 ACADIA Pharmaceuticals Inc. 发明人 Peters Perry;Furlano David;Bahr Daun;Van Kammen Daniel;Brann Mark
分类号 A61K31/4468;A61K31/519;A61K31/496;A61K31/554;G06F19/00;A61K45/06;A61K33/00;A61K31/454;A61K49/00;A61K31/451;A61K31/435 主分类号 A61K31/4468
代理机构 代理人
主权项 1. A method of treating a condition amenable to treatment with an antipsychotic, comprising: administering a first amount of a 5-HT2A inverse agonist or antagonist; and administering a second amount of an antipsychotic agent, wherein the first and second amounts are such that an efficacious effect is achieved faster than when the antipsychotic agent is administered alone at an efficacious dose.
地址 San Diego CA US